InsidersTradesSigma
Track the MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Market capitalisation: €53.5m. The latest transaction was disclosed on 3 June 2026 (Initial Substantial Holding). Among the most active insiders: NFPFRN (if applicable). All data is accessible without an account.
Analysts rate MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED Strong Buy (bullish), based on 2 analysts. Average price target: A$2.29.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Medical Developments International Limited is an Australian company focused on developing medical products, particularly pain management devices. It is listed on the Australian Securities Exchange under the ticker XASX.